RUNX3 attenuates β-catenin/T cell factors in intestinal tumorigenesis

被引:209
作者
Ito, Kosei [1 ,2 ]
Lim, Anthony Chee-Beng [1 ]
Salto-Tellez, Manuel [2 ]
Motoda, Lena [1 ]
Osato, Motomi [1 ,2 ]
Shyue, Linda [1 ]
Chuang, Huey [1 ]
Lee, Cecilia Wei Lin [1 ]
Voon, Dominic Chih-Cheng [1 ]
Koo, Jason Kin Wai [2 ]
Wang, Huajing [2 ]
Fukamachi, Hiroshi [3 ]
Ito, Yoshiaki [1 ,2 ]
机构
[1] Inst Mol & Cell Biol, Singapore 138673, Singapore
[2] Natl Univ Singapore, Oncol Res Inst, Yong Loo Lin Sch Med, Singapore 117456, Singapore
[3] Tokyo Med & Dent Univ, Dept Mol Oncol, Bunkyo Ku, Tokyo 1138519, Japan
关键词
D O I
10.1016/j.ccr.2008.08.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In intestinal epithelial cells, inactivation of APC, a key regulator of the Wnt pathway, activates beta-catenin to initiate tumorigenesis. However, other alterations may be involved in intestinal tumorigenesis. Here we found that RUNX3, a gastric tumor suppressor, forms a ternary complex with beta-catenin/7CF4 and attenuates Wnt signaling activity. A significant fraction of human sporadic colorectal adenomas and Runx3(+/-) mouse intestinal adenomas showed inactivation of RUNX3 without apparent beta-catenin accumulation, indicating that RUNX3 inactivation independently induces intestinal adenomas. In human colon cancers, RUNX3 is frequently inactivated with concomitant beta-catenin accumulation, suggesting that adenomas induced by inactivation of RUNX3 may progress to malignancy. Taken together, these data demonstrate that RUNX3 functions as a tumor suppressor by attenuating Wnt signaling.
引用
收藏
页码:226 / 237
页数:12
相关论文
共 40 条
[1]   Crypt-restricted proliferation and commitment to the Paneth cell lineage following Apc loss in the mouse intestine [J].
Andreu, P ;
Colnot, S ;
Godard, C ;
Gad, S ;
Chafey, P ;
Niwa-Kawakita, M ;
Laurent-Puig, P ;
Kahn, A ;
Robine, S ;
Perret, C ;
Romagnolo, B .
DEVELOPMENT, 2005, 132 (06) :1443-1451
[2]   β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB [J].
Batlle, E ;
Henderson, JT ;
Beghtel, H ;
van den Born, MMW ;
Sancho, E ;
Huls, G ;
Meeldijk, J ;
Robertson, J ;
van de Wetering, M ;
Pawson, T ;
Clevers, H .
CELL, 2002, 111 (02) :251-263
[3]   The RUNX genes: Gain or loss of function in cancer [J].
Blyth, K ;
Cameron, ER ;
Neil, JC .
NATURE REVIEWS CANCER, 2005, 5 (05) :376-387
[4]   Cancer genetics: colorectal cancer as a model [J].
Bodmer, WF .
JOURNAL OF HUMAN GENETICS, 2006, 51 (05) :391-396
[5]   Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia [J].
Brenner, O ;
Levanon, D ;
Negreanu, V ;
Golubkov, O ;
Fainaru, O ;
Woolf, E ;
Groner, Y .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (45) :16016-16021
[6]   RUNX3 suppresses gastric epithelial cell growth by inducing p21WAF1/Cip1 expression in cooperation with transforming growth factor β-activated SMAD [J].
Chi, XZ ;
Yang, JO ;
Lee, KY ;
Ito, K ;
Sakakura, C ;
Li, QL ;
Kim, HR ;
Cha, EJ ;
Lee, YH ;
Kaneda, A ;
Ushijima, T ;
Kim, WJ ;
Ito, Y ;
Bae, SC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (18) :8097-8107
[7]   TGF-β signaling in tumor suppression and cancer progression [J].
Derynck, R ;
Akhurst, RJ ;
Balmain, A .
NATURE GENETICS, 2001, 29 (02) :117-129
[8]   Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers [J].
Goel, A ;
Arnold, CN ;
Tassone, P ;
Chang, DK ;
Niedzwiecki, D ;
Dowell, JM ;
Wasserman, L ;
Compton, C ;
Mayer, RJ ;
Bertagnolli, MM ;
Boland, CR .
INTERNATIONAL JOURNAL OF CANCER, 2004, 112 (05) :754-759
[9]   The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer [J].
Goel, Ajay ;
Nagasaka, Takeshi ;
Arnold, Christian N. ;
Inoue, Toru ;
Hamilton, Cody ;
Niedzwiecki, Donna ;
Compton, Carolyn ;
Mayer, Robert J. ;
Goldberg, Richard ;
Bertagnolli, Monica M. ;
Boland, C. Richard .
GASTROENTEROLOGY, 2007, 132 (01) :127-138
[10]   Inhibition of growth of mouse gastric cancer cells by Runx3, a novel tumor suppressor [J].
Guo, WH ;
Weng, LQ ;
Ito, K ;
Chen, LF ;
Nakanishi, H ;
Tatematsu, M ;
Ito, Y .
ONCOGENE, 2002, 21 (54) :8351-8355